Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

CHRSCHRS
30 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in COHERUS ONCOLOGY INC

Yes. Northern Trust holds 1,129,470 shares of CHRS (Coherus Oncology), worth $1.6M, as of its Q2 2026 13F filing. It increased the position by 215,670 shares (+23.6%) from Q1 2026. Northern Trust has held CHRS in every 13F on record since Q1 2019, 30 quarterly filings.

Current Value

$1.6M

Current Shares

1.1M

Total Value Change

-$7.5M

Total Shares Change

+464,851

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.1M
+23.6%
$1.6M0.0%$1.40
31
2026-Q1
Increased
913,800
+15.2%
$1.5M0.0%$1.69
29
2025-Q4
Decreased
793,313
-6.7%
$1.1M0.0%$1.42
0
2025-Q3
Decreased
850,418
-5.1%
$1.4M0.0%$1.64
0
2025-Q2
Decreased
895,708
-5.4%
$655,0320.0%$0.73
0
2025-Q1
Decreased
947,124
-5.9%
$764,3300.0%$0.81
0
2024-Q4
Increased
1M
+12.2%
$1.4M0.0%$1.38
29
2024-Q3
Decreased
896,735
-1.9%
$932,6050.0%$1.04
0
2024-Q2
Decreased
913,746
-0.9%
$1.6M0.0%$1.73
0
2024-Q1
Decreased
921,641
-4.6%
$2.2M0.0%$2.39
0
2023-Q4
Increased
966,018
+0.4%
$3.2M0.0%$3.33
26
2023-Q3
Increased
962,345
+20.9%
$3.6M0.0%$3.74
32
2023-Q2
Increased
796,237
+4.3%
$3.4M0.0%$4.27
28
2023-Q1
Increased
763,668
+1.7%
$5.2M0.0%$6.84
27
2022-Q4
Decreased
751,020
-0.8%
$5.9M0.0%$7.92
0
2022-Q3
Increased
757,124
+1.4%
$7.3M0.0%$9.61
28
2022-Q2
Increased
746,844
+5.9%
$5.4M0.0%$7.24
29
2022-Q1
Decreased
705,200
-3.5%
$9.1M0.0%$12.91
0
2021-Q4
Decreased
731,102
-1.4%
$11.7M0.0%$15.96
0
2021-Q3
Decreased
741,234
-2.5%
$11.9M0.0%$16.07
0
2021-Q2
Increased
760,409
+5.5%
$10.5M0.0%$13.83
29
2021-Q1
Decreased
720,775
-4.6%
$10.5M0.0%$14.61
0
2020-Q4
Decreased
755,823
-2.3%
$13.1M0.0%$17.38
0
2020-Q3
Decreased
773,746
-4.4%
$14.2M0.0%$18.34
0
2020-Q2
Increased
809,305
+3.7%
$14.5M0.0%$17.86
29
2020-Q1
Increased
780,594
+0.3%
$12.7M0.0%$16.22
28
2019-Q4
Decreased
778,631
-1.6%
$14M0.0%$18.01
0
2019-Q3
Increased
791,226
+13.6%
$16M0.0%$20.26
32
2019-Q2
Increased
696,453
+4.8%
$15.4M0.0%$22.10
30
2019-Q1
First report
664,619
-
$9.1M0.0%$13.64
0

Other major holders of CHRS: Temasek Holdings (Private) Ltd, WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used